Centus Biotherapeutics is Biotechnology in United Kingdom that focus on monoclonal antibody business. Founded in 2015. They cover business area such as developer, antibody, multiple solid tumor, bevacizumab, establish efficacy, cancer.
2015
( 9 years old in 2024 )
Monoclonal Antibody
-
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA
England, United Kingdom
Private
developerantibodymultiple solid tumorbevacizumabestablish efficacycancer
* We use standard office opening hours in near Centus Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Centus Biotherapeutics is Biotechnology business from United Kingdom that founded in 2015 (9 years old in 2024), Centus Biotherapeutics business is focusing on Monoclonal Antibody.
Centus Biotherapeutics headquarter office and corporate office address is located in 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA England, United Kingdom.
Centus Biotherapeutics was founded in United Kingdom.
In 2024, Centus Biotherapeutics is currently focus on monoclonal antibody sector.
Above is snippet of Google Trends for "monoclonal antibody" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Centus Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
